#Zolgensma #Zolgensma #Zolgensma

Zolgensma Approved!

AveXis, a Novartis company, has received FDA approval for Zolgensma.

Learn MoreLearn More

Cure SMA Releases Status Update on Data Accuracy Issues with Zolgensma

Yesterday, the FDA...

READ MORE

FDA Issues Statement on Data Accuracy Issues with Recently Approved Gene Therapy

Today, the FDA...

READ MORE

Biogen Issues Community Statement on Spinraza

Biogen Issues Community Statement on Spinraza

Biogen has provided the following community statement on Spinraza. 

Dear members of the SMA community,

Following a busy...

READ MORE

SMA Awareness Month 2019 Has Begun!

SMA Awareness Month 2019 Has Begun!

The SMA community officially recognizes August as Spinal Muscular Atrophy Awareness Month and Cure SMA has been coordinating activities since...

READ MORE

Cure SMA Welcomes the New North Florida and Oklahoma Chapters

Cure SMA Welcomes the New North Florida and Oklahoma Chapters

Cure SMA is pleased to announce the creation of two new chapters: North Florida and Oklahoma. The chapters are eager to begin helping families...

READ MORE

© 2019 Cure SMA | Cure SMA is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 36-3320440. | Privacy Policy

Powered by Blackbaud
nonprofit software